DE602005017807D1 - Angiotensin-(1-7) freisetzende polymerbeschichtete medizinische vorrichtung zur reduzierung von restenose und zur verbesserung von endothelzellfunktionen - Google Patents
Angiotensin-(1-7) freisetzende polymerbeschichtete medizinische vorrichtung zur reduzierung von restenose und zur verbesserung von endothelzellfunktionenInfo
- Publication number
- DE602005017807D1 DE602005017807D1 DE602005017807T DE602005017807T DE602005017807D1 DE 602005017807 D1 DE602005017807 D1 DE 602005017807D1 DE 602005017807 T DE602005017807 T DE 602005017807T DE 602005017807 T DE602005017807 T DE 602005017807T DE 602005017807 D1 DE602005017807 D1 DE 602005017807D1
- Authority
- DE
- Germany
- Prior art keywords
- angiotensin
- medical device
- endothelial cell
- cell functions
- coated medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62146204P | 2004-10-21 | 2004-10-21 | |
PCT/US2005/037895 WO2006047289A2 (en) | 2004-10-21 | 2005-10-21 | Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005017807D1 true DE602005017807D1 (de) | 2009-12-31 |
Family
ID=36228278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005017807T Active DE602005017807D1 (de) | 2004-10-21 | 2005-10-21 | Angiotensin-(1-7) freisetzende polymerbeschichtete medizinische vorrichtung zur reduzierung von restenose und zur verbesserung von endothelzellfunktionen |
Country Status (5)
Country | Link |
---|---|
US (1) | US7176261B2 (de) |
EP (1) | EP1802361B1 (de) |
AT (1) | ATE448813T1 (de) |
DE (1) | DE602005017807D1 (de) |
WO (1) | WO2006047289A2 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7611533B2 (en) * | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
US20030093143A1 (en) * | 1999-03-01 | 2003-05-15 | Yiju Zhao | Medical device having surface depressions containing nitric oxide releasing compound |
US7349971B2 (en) * | 2004-02-05 | 2008-03-25 | Scenera Technologies, Llc | System for transmitting data utilizing multiple communication applications simultaneously in response to user request without specifying recipient's communication information |
US8236338B2 (en) | 2004-07-13 | 2012-08-07 | The University Of Tennessee Research Foundation | Adhesive composition for carrying therapeutic agents as delivery vehicle on coatings applied to vascular grafts |
US20070142905A1 (en) * | 2005-12-16 | 2007-06-21 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
BRPI0602372B8 (pt) * | 2006-05-18 | 2021-06-22 | Einco Biomaterial Ltda | processo de preparação de compósitos em base de biocerâmicas e polímeros biodegradáveis e produto derivado |
US20080057104A1 (en) * | 2006-09-01 | 2008-03-06 | Joseph Walker | Matrix metalloproteinase inhibitor delivering devices |
WO2008052179A2 (en) * | 2006-10-27 | 2008-05-02 | Medtronic, Inc. | Angiotensin (1-7) eluting stent |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
US8430055B2 (en) | 2008-08-29 | 2013-04-30 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414909B2 (en) * | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414910B2 (en) * | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
JP2008305262A (ja) * | 2007-06-08 | 2008-12-18 | Konica Minolta Business Technologies Inc | サーバ及びシンクライアント環境でのプリンタ紹介方法 |
WO2009009587A2 (en) * | 2007-07-09 | 2009-01-15 | Board Of Regents Of The University Of Nebraska | Apoptosis-modulating protein therapy for proliferative disorders and nanoparticles containing the same |
US7828840B2 (en) * | 2007-11-15 | 2010-11-09 | Med Institute, Inc. | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists |
US20090299466A1 (en) * | 2008-06-02 | 2009-12-03 | Medtronic Vascular, Inc. | Local Delivery of Matrix Metalloproteinase Inhibitors |
US9289540B2 (en) * | 2009-05-08 | 2016-03-22 | Greatbatch Ltd. | Surface modification for coating |
WO2014070792A1 (en) | 2012-10-29 | 2014-05-08 | Ariste Medical, Inc. | Polymer coating compositions and coated products |
GB2537770B (en) | 2014-04-22 | 2017-09-13 | Ariste Medical Llc | Methods and processes for application of drug delivery polymeric coatings |
US11058804B2 (en) * | 2017-06-13 | 2021-07-13 | Ethicon Llc | Surgical fastener device for the prevention of ECM degradation |
US10939911B2 (en) | 2017-06-13 | 2021-03-09 | Ethicon Llc | Surgical stapler with end effector coating |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3611307A1 (de) * | 1985-04-05 | 1986-10-09 | Okura Kogyo K.K., Marugame, Kagawa | Radikalpolymerisations-zusammensetzung und diese enthaltende anaerobe fluessige dichtungsmittel |
JP2571787B2 (ja) * | 1987-05-14 | 1997-01-16 | 株式会社クラレ | 離型性の改良された成形品の製造方法 |
US4961532A (en) * | 1989-07-07 | 1990-10-09 | Dow Corning Corporation | Fragrance release device containing a highly adsorptive copolymer |
JPH04317025A (ja) * | 1991-04-17 | 1992-11-09 | Mitsubishi Kasei Corp | 調光材料及びそれを含む調光素子 |
AU2650692A (en) | 1991-09-16 | 1993-04-27 | Schering Corporation | Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5955430A (en) | 1993-09-24 | 1999-09-21 | University Of Southern California | Use of angiotensin II fragments and analogs thereof in tissue repair |
US5834432A (en) | 1995-06-06 | 1998-11-10 | The University Of Southern California | Use of angiotensin II Type 2 receptor agonists in tissue repair |
US6160114A (en) | 1996-11-14 | 2000-12-12 | American Home Products Corporation | Substituted tetrahydro-1,3,5-triazin-2[1H]-thiones as anti-atherosclerotic agents |
WO1999009192A1 (en) | 1997-08-15 | 1999-02-25 | Inex Pharmaceuticals Corporation | Semliki forest virus vectors for gene transfer into non-endothelial cardiovascular cells |
US6140127A (en) | 1998-02-18 | 2000-10-31 | Cordis Corporation | Method of coating an intravascular stent with an endothelial cell adhesive five amino acid peptide |
DE19825494A1 (de) * | 1998-06-08 | 1999-12-09 | Hoechst Marion Roussel De Gmbh | Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben |
YU78601A (sh) | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
US6251136B1 (en) * | 1999-12-08 | 2001-06-26 | Advanced Cardiovascular Systems, Inc. | Method of layering a three-coated stent using pharmacological and polymeric agents |
EP1248653A2 (de) | 2000-01-07 | 2002-10-16 | Stichting Klinische Farmacologie Groningen | Gentherapie zur förderung von angiogenese sowie zur behandlung von herzinsuffienz |
US20050142130A1 (en) * | 2001-01-04 | 2005-06-30 | Roks Antonius J.M. | Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima |
DE10112041A1 (de) | 2001-03-14 | 2002-09-26 | Aventis Pharma Gmbh | p-Thienylbenzyl-Amide als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US7048939B2 (en) | 2001-04-20 | 2006-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for the inhibition of neointima formation |
US20020168393A1 (en) * | 2001-05-08 | 2002-11-14 | Ryota Sugimoto | Implantable medical material and implantable medical device |
BRPI0105509B8 (pt) | 2001-11-05 | 2021-05-25 | Univ Minas Gerais | formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga |
CA2475953A1 (en) * | 2002-02-27 | 2003-09-04 | E. Ann Tallant | Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
WO2003079936A1 (en) * | 2002-03-18 | 2003-10-02 | Medtronic Ave Inc. | Medical devices for delivering anti-proliferative compositions to anatomical sites at risk for restenosis |
EP1348440A1 (de) | 2002-03-28 | 2003-10-01 | Citeq B.V. | Verwendung von Angiotensin 1-7 zu Verbesserung der Herzfunktion |
US20050119180A1 (en) | 2002-03-28 | 2005-06-02 | Roks Antonius J.M. | Use of angiotensin 1-7 for enhancing cardiac function |
US8414874B2 (en) * | 2002-04-24 | 2013-04-09 | Poly-Med, Inc. | Multifaceted endovascular stent coating for preventing restenosis |
US20040127978A1 (en) * | 2002-08-13 | 2004-07-01 | Medtronic, Inc. | Active agent delivery system including a hydrophilic polymer, medical device, and method |
US6770729B2 (en) | 2002-09-30 | 2004-08-03 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
US7211108B2 (en) * | 2004-01-23 | 2007-05-01 | Icon Medical Corp. | Vascular grafts with amphiphilic block copolymer coatings |
US20050214339A1 (en) * | 2004-03-29 | 2005-09-29 | Yiwen Tang | Biologically degradable compositions for medical applications |
US20060088571A1 (en) * | 2004-10-21 | 2006-04-27 | Medtronic Vascular, Inc. | Biocompatible and hemocompatible polymer compositions |
-
2005
- 2005-10-21 EP EP05817342A patent/EP1802361B1/de not_active Not-in-force
- 2005-10-21 US US11/256,582 patent/US7176261B2/en not_active Expired - Fee Related
- 2005-10-21 AT AT05817342T patent/ATE448813T1/de not_active IP Right Cessation
- 2005-10-21 DE DE602005017807T patent/DE602005017807D1/de active Active
- 2005-10-21 WO PCT/US2005/037895 patent/WO2006047289A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US7176261B2 (en) | 2007-02-13 |
WO2006047289A2 (en) | 2006-05-04 |
EP1802361A2 (de) | 2007-07-04 |
WO2006047289A3 (en) | 2007-04-12 |
US20060088572A1 (en) | 2006-04-27 |
EP1802361B1 (de) | 2009-11-18 |
ATE448813T1 (de) | 2009-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005017807D1 (de) | Angiotensin-(1-7) freisetzende polymerbeschichtete medizinische vorrichtung zur reduzierung von restenose und zur verbesserung von endothelzellfunktionen | |
ATE540709T1 (de) | Implantierbare medizinische vorrichtung mit partikelbeschichtung | |
HK1139030A1 (en) | Surgical articles for treating pelvic conditions | |
HK1133378A1 (en) | Surgical articles for treating pelvic conditions | |
TW200605853A (en) | Steroid-containing sustained release intraocular implants and related methods | |
WO2005099621A3 (en) | Topographic coatings and coating methods for medical devices | |
ATE448812T1 (de) | Beschichtung von stents mit verzögerter wirkstofffreisetzung | |
WO2007133382A3 (en) | Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers | |
MX2009012766A (es) | Stent absorbible con un recubrimiento para controlar la degradacion del stent y mantener la neutralidad del ph. | |
WO2009144580A3 (en) | Coatings for promoting endothelization of medical devices | |
TW200512016A (en) | Drug-coated stents and methods of use therefor | |
WO2008011093A3 (en) | Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders | |
ATE451130T1 (de) | Phospholipid und verunreinigungsbeständige beschichtungszusammensetzungen | |
ATE441381T1 (de) | Gerät zur ablage von gerollten prothesen | |
MX2007005723A (es) | Articulos para tratamiento que pueden amoldarse a una forma subyacente. | |
ATE502663T1 (de) | Medizinische vorrichtungen mit einem porösen metalloxid- oder metallmaterial und einer polymerbeschichtung zur freisetzung von therapeutika | |
WO2007106520A3 (en) | Heatable sling support for an anatomical location | |
ATE423990T1 (de) | Verfahren und zusammensetzungen zur behandlung von uveitis | |
WO2006047378A3 (en) | Biocompatible and hemocompatible amphiphilic coatings for drug deliver | |
DE10294792D2 (de) | Beschichtung von Stents zur Verhinderung von Restenose | |
WO2007145909A3 (en) | Methods and compositions for treating post-myocardial infarction damage | |
DE602004022834D1 (de) | Biologisch absorbierbare überzüge für implantierbare vorrichtungen | |
WO2006086693A3 (en) | Medical devices | |
WO2008109347A3 (en) | Methods for ex vivo administration of drugs to grafts using polymeric nanoparticles | |
MX2009006870A (es) | Dispositivo para mitigar el olor en un articulo de ropa o calzado. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |